Nuvig Therapeutics
Latest round
- Series B
Last raised
- Dec 2024
Total raised
- $61M
Investors
- 14
About Nuvig Therapeutics
, aka Nuvig, operates as a provider of therapeutic platform that offers clinical solutions to patients dealing with diseases such as malignants and others. In December 2024, Nuvig Therapeutics, Inc., Bristol-Myers Squibb Company, Digitalis Ventures, Mission BioCapital, Novo Holdings, and Platanus Ventures. The firm offers therapeutic medications in the form of protein, antibodies, and others for patients suffering from health issues due to immune disorders.
Who invested in Nuvig Therapeutics
14 investors across 2 rounds
See all investors in Nuvig Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nuvig Therapeutics
Who invested in Nuvig Therapeutics?
Nuvig Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuvig Therapeutics raised?
Nuvig Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nuvig Therapeutics last raise money?
Nuvig Therapeutics's most recent round on record is a Series B, in Dec 2024.
What does Nuvig Therapeutics do?
, aka Nuvig, operates as a provider of therapeutic platform that offers clinical solutions to patients dealing with diseases such as malignants and others.
Where is Nuvig Therapeutics headquartered?
Nuvig Therapeutics is headquartered in Menlo Park, US.
Which VCs invest in companies like Nuvig Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nuvig Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nuvig Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.